Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease) [Original Articles]

Conclusions Patients with amio-refractory VT have a higher rate of ventricular arrhythmia and mortality than those with sotalol-refractory VT and derive greater benefit of catheter ablation than for patients with sotalol-refractory VT who are switched to amiodarone. CLINICAL TRIAL REGISTRATION URL: https://clinicaltrials.gov. Unique identifier: NCT00905853.

http://circep.ahajournals.org/cgi/content/short/11/1/e005663?rss=1

Source: Circulation: Arrhythmia and Electrophysiology - January 5, 2018 Category: Cardiology Authors: Parkash, R., Nault, I., Rivard, L., Gula, L., Essebag, V., Nery, P., Tung, S., Raymond, J.-M., Sterns, L., Doucette, S., Wells, G., Tang, A. S. L., Stevenson, W. G., Sapp, J. L. Tags: Arrhythmias, Catheter Ablation and Implantable Cardioverter-Defibrillator, Clinical Studies Original Articles Source Type: research